Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium. / Borkar, Nrupa Nitin; Xia, Dengning; Holm, René; Gan, Yong; Müllertz, Anette; Yang, Mingshi; Mu, Huiling.

In: European Journal of Pharmaceutical Sciences, Vol. 51, 2014, p. 204-10.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Borkar, NN, Xia, D, Holm, R, Gan, Y, Müllertz, A, Yang, M & Mu, H 2014, 'Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium', European Journal of Pharmaceutical Sciences, vol. 51, pp. 204-10. https://doi.org/10.1016/j.ejps.2013.09.022

APA

Borkar, N. N., Xia, D., Holm, R., Gan, Y., Müllertz, A., Yang, M., & Mu, H. (2014). Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium. European Journal of Pharmaceutical Sciences, 51, 204-10. https://doi.org/10.1016/j.ejps.2013.09.022

Vancouver

Borkar NN, Xia D, Holm R, Gan Y, Müllertz A, Yang M et al. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium. European Journal of Pharmaceutical Sciences. 2014;51:204-10. https://doi.org/10.1016/j.ejps.2013.09.022

Author

Borkar, Nrupa Nitin ; Xia, Dengning ; Holm, René ; Gan, Yong ; Müllertz, Anette ; Yang, Mingshi ; Mu, Huiling. / Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium. In: European Journal of Pharmaceutical Sciences. 2014 ; Vol. 51. pp. 204-10.

Bibtex

@article{2a419427932d4aeea82924f444919a7d,
title = "Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium",
abstract = "Lipid matrix particles (LMP) may be used as better carriers for poorly water-soluble drugs than liquid lipid carriers because of reduced drug mobilization in the formulations. However, the digestion process of solid lipid particles and their effect on the absorption of poorly water-soluble drugs are not fully understood. This study aimed at investigating the effect of particle size of LMP on drug release in vitro as well as absorption in vivo in order to get a better understanding on the effect of degradation of lipid particles on drug solubilisation and absorption. Fenofibrate, a model poorly water-soluble drug, was incorporated into LMP in this study using probe ultrasound sonication. The resultant LMP were characterised in terms of particle size, size distribution, zeta potential, entrapment efficiency, in vitro lipolysis and in vivo absorption in rat model. LMP of three different particle sizes i.e. approximately 100 nm, 400 nm, and 10 μm (microparticles) were produced with high entrapment efficiencies. The in vitro lipolysis study showed that the recovery of fenofibrate in the aqueous phase for 100 nm and 400 nm LMP was significantly higher (p<0.05) than that of microparticles after 30 min of lipolysis, suggesting that nano-sized LMP were digested to a larger extent due to greater specific surface area. The 100 nm LMP showed faster initial digestion followed by 400 nm LMP and microparticles. The area under the plasma concentration-time curve (AUC) following oral administration of 100 nm LMP was significantly higher (p<0.01) (control). ({\%}) 100 400 absorption acid and aqueous auc aucs between concentration-time crystalline curve difference during fenofibrate fenofibric however, in into lipolysis lmp lmp. microparticles nm no observed observed. of on order partitioning phase plasma rank recovery response same significant suspension than that the vitro vivo was>microparticles>control. In summary, the present study demonstrated the particle size dependence of bioavailability of fenofibrate loaded LMP in rat model which correlates well with the in vitro drug release performed in the biorelevant medium.",
author = "Borkar, {Nrupa Nitin} and Dengning Xia and Ren{\'e} Holm and Yong Gan and Anette M{\"u}llertz and Mingshi Yang and Huiling Mu",
note = "Copyright {\circledC} 2013 Elsevier B.V. All rights reserved.",
year = "2014",
doi = "10.1016/j.ejps.2013.09.022",
language = "English",
volume = "51",
pages = "204--10",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium

AU - Borkar, Nrupa Nitin

AU - Xia, Dengning

AU - Holm, René

AU - Gan, Yong

AU - Müllertz, Anette

AU - Yang, Mingshi

AU - Mu, Huiling

N1 - Copyright © 2013 Elsevier B.V. All rights reserved.

PY - 2014

Y1 - 2014

N2 - Lipid matrix particles (LMP) may be used as better carriers for poorly water-soluble drugs than liquid lipid carriers because of reduced drug mobilization in the formulations. However, the digestion process of solid lipid particles and their effect on the absorption of poorly water-soluble drugs are not fully understood. This study aimed at investigating the effect of particle size of LMP on drug release in vitro as well as absorption in vivo in order to get a better understanding on the effect of degradation of lipid particles on drug solubilisation and absorption. Fenofibrate, a model poorly water-soluble drug, was incorporated into LMP in this study using probe ultrasound sonication. The resultant LMP were characterised in terms of particle size, size distribution, zeta potential, entrapment efficiency, in vitro lipolysis and in vivo absorption in rat model. LMP of three different particle sizes i.e. approximately 100 nm, 400 nm, and 10 μm (microparticles) were produced with high entrapment efficiencies. The in vitro lipolysis study showed that the recovery of fenofibrate in the aqueous phase for 100 nm and 400 nm LMP was significantly higher (p<0.05) than that of microparticles after 30 min of lipolysis, suggesting that nano-sized LMP were digested to a larger extent due to greater specific surface area. The 100 nm LMP showed faster initial digestion followed by 400 nm LMP and microparticles. The area under the plasma concentration-time curve (AUC) following oral administration of 100 nm LMP was significantly higher (p<0.01) (%) (control). 100 400 absorption acid and aqueous auc aucs between concentration-time crystalline curve difference during fenofibrate fenofibric however, in into lipolysis lmp lmp. microparticles nm no observed observed. of on order partitioning phase plasma rank recovery response same significant suspension than that the vitro vivo was>microparticles>control. In summary, the present study demonstrated the particle size dependence of bioavailability of fenofibrate loaded LMP in rat model which correlates well with the in vitro drug release performed in the biorelevant medium.

AB - Lipid matrix particles (LMP) may be used as better carriers for poorly water-soluble drugs than liquid lipid carriers because of reduced drug mobilization in the formulations. However, the digestion process of solid lipid particles and their effect on the absorption of poorly water-soluble drugs are not fully understood. This study aimed at investigating the effect of particle size of LMP on drug release in vitro as well as absorption in vivo in order to get a better understanding on the effect of degradation of lipid particles on drug solubilisation and absorption. Fenofibrate, a model poorly water-soluble drug, was incorporated into LMP in this study using probe ultrasound sonication. The resultant LMP were characterised in terms of particle size, size distribution, zeta potential, entrapment efficiency, in vitro lipolysis and in vivo absorption in rat model. LMP of three different particle sizes i.e. approximately 100 nm, 400 nm, and 10 μm (microparticles) were produced with high entrapment efficiencies. The in vitro lipolysis study showed that the recovery of fenofibrate in the aqueous phase for 100 nm and 400 nm LMP was significantly higher (p<0.05) than that of microparticles after 30 min of lipolysis, suggesting that nano-sized LMP were digested to a larger extent due to greater specific surface area. The 100 nm LMP showed faster initial digestion followed by 400 nm LMP and microparticles. The area under the plasma concentration-time curve (AUC) following oral administration of 100 nm LMP was significantly higher (p<0.01) (%) (control). 100 400 absorption acid and aqueous auc aucs between concentration-time crystalline curve difference during fenofibrate fenofibric however, in into lipolysis lmp lmp. microparticles nm no observed observed. of on order partitioning phase plasma rank recovery response same significant suspension than that the vitro vivo was>microparticles>control. In summary, the present study demonstrated the particle size dependence of bioavailability of fenofibrate loaded LMP in rat model which correlates well with the in vitro drug release performed in the biorelevant medium.

U2 - 10.1016/j.ejps.2013.09.022

DO - 10.1016/j.ejps.2013.09.022

M3 - Journal article

C2 - 24134899

VL - 51

SP - 204

EP - 210

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

ER -

ID: 45808028